These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 19730388)
21. Obsessive-compulsive disorder and comorbid depression: the role of OCD-related and non-specific factors. Yap K; Mogan C; Kyrios M J Anxiety Disord; 2012 Jun; 26(5):565-73. PubMed ID: 22495108 [TBL] [Abstract][Full Text] [Related]
22. What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label study. Shim G; Park HY; Jang JH; Kim E; Park HY; Hwang JY; Kim SN; Jang GE; Kwon JS Int Clin Psychopharmacol; 2011 Sep; 26(5):284-90. PubMed ID: 21829108 [TBL] [Abstract][Full Text] [Related]
23. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study. Stryjer R; Dambinsky Y; Timinsky I; Green T; Kotler M; Weizman A; Spivak B Int Clin Psychopharmacol; 2013 Mar; 28(2):96-8. PubMed ID: 23211492 [TBL] [Abstract][Full Text] [Related]
24. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. Hollander E; Stein DJ; Fineberg NA; Marteau F; Legault M J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845 [TBL] [Abstract][Full Text] [Related]
25. Open-label escitalopram treatment for pathological skin picking. Keuthen NJ; Jameson M; Loh R; Deckersbach T; Wilhelm S; Dougherty DD Int Clin Psychopharmacol; 2007 Sep; 22(5):268-74. PubMed ID: 17690595 [TBL] [Abstract][Full Text] [Related]
27. [Clinical efficacy of citalopram in patients with obsessive-compulsive disorder]. Jakitowicz J; Nowicki Z; Wiśniewski G Psychiatr Pol; 2002; 36(6 Suppl):297-301. PubMed ID: 12647452 [TBL] [Abstract][Full Text] [Related]
28. The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study. Rubin-Kahana DS; Shelef A; Weizman A; Gothelf D; Timinski I; Spivak B; Stryjer R Int Clin Psychopharmacol; 2019 Jul; 34(4):179-183. PubMed ID: 31058717 [TBL] [Abstract][Full Text] [Related]
29. Open-label pilot study of memantine in the treatment of compulsive buying. Grant JE; Odlaug BL; Mooney M; O'Brien R; Kim SW Ann Clin Psychiatry; 2012 May; 24(2):119-26. PubMed ID: 22563566 [TBL] [Abstract][Full Text] [Related]
30. An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. Grant P; Lougee L; Hirschtritt M; Swedo SE J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):761-7. PubMed ID: 18315448 [TBL] [Abstract][Full Text] [Related]
31. Obsessive-compulsive disorder: an open-label pilot trial of escitalopram. Galvão-de Almeida A; Quarantini LC; Góis CR; Santos-Jesus R; Miranda-Scippa AM; de Oliveira IR; da Silva Prado H; Leckman JF; Rosário MC CNS Spectr; 2007 Jul; 12(7):519-24. PubMed ID: 17603402 [TBL] [Abstract][Full Text] [Related]
32. Sarcosine therapy for obsessive compulsive disorder: a prospective, open-label study. Wu PL; Tang HS; Lane HY; Tsai CA; Tsai GE J Clin Psychopharmacol; 2011 Jun; 31(3):369-74. PubMed ID: 21508860 [TBL] [Abstract][Full Text] [Related]
33. An open-label study of nefazodone in the treatment of depression with and without comorbid obsessive compulsive disorder. Nelson EC Ann Clin Psychiatry; 1994 Dec; 6(4):249-53. PubMed ID: 7647834 [TBL] [Abstract][Full Text] [Related]
34. Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study. Sarris J; Byrne GJ; Oliver G; Cribb L; Blair-West S; Castle D; Dean OM; Camfield DA; Brakoulias V; Bousman C; Dowling N; Ee C; Murphy J; Menon R; Berk M; Chamoli S; Boschen M; Ng CH CNS Spectr; 2022 Oct; 27(5):588-597. PubMed ID: 34165060 [TBL] [Abstract][Full Text] [Related]
35. Citalopram and psychotic symptoms. Lamps CA J Am Acad Child Adolesc Psychiatry; 2002 Jan; 41(1):6. PubMed ID: 11800209 [No Abstract] [Full Text] [Related]